减少放射性标记抗体对正常组织辐射的方法
Hiroyuki Suzuki1, Kento Kannaka1, Tomoya Uehara1
1Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.
Pharmaceuticals (Basel, Switzerland)
|April 27, 2024
概括
研究人员正在改进放射性标记抗体,用于核医学成像和治疗. 新的策略提高了体内稳定性和生物分布,克服了更好的临床应用的局限性.
科学领域:
- 核医学是一种核医学.
- 放射性药物科学 放射性药物科学
背景情况:
- 放射性标记抗体对于核医学成像和治疗至关重要.
- 已建立的放射性标记协议确保了许多放射性核素的高in vivo稳定性.
- 局限性仍然存在,包括对抗体生物分布的不良影响.
研究的目的:
- 审查改善放射性标记抗体方面的努力和最近的进展.
- 解决抗体生物分布和体内稳定性的挑战.
- 讨论新方法的临床潜力.
主要方法:
- 预定目标策略的策略.
- 工程制造的抗体碎片和结构.
- 清算剂的二次注射清算剂的二次注射
- 插入可代谢的链接.
主要成果:
- 许多临床前研究表明,在克服局限性方面取得了进展.
- 新方法在增强生物分布和稳定性方面显示出前途.
- 目前正在探索临床翻译的几种方法.
结论:
- 在临床前研究方面取得了重大进展.
- 新的策略为当前的局限性提供了潜在的解决方案.
- 预计这些改进的放射性标记抗体的进一步临床应用.
相关概念视频
Imaging Studies II: Positron Emission Tomography and Scintigraphy
112
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
112
Immunogold Electron Microscopy
4.0K
Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.
4.0K


